e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Biomarkers in inflammatory lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Polymorphisms associated with lung cancer are closely related to COPD
M. V. Vasilyeva, N. V. Cherdyntseva, P. A. Gervas, V. A. Belyavskaya, M. B. Freidin (Tomsk, Kol‘tsovo, Novosibirsk Region, Russian Federation)
Source:
Annual Congress 2007 - Biomarkers in inflammatory lung disease
Session:
Biomarkers in inflammatory lung disease
Session type:
Thematic Poster Session
Number:
901
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. V. Vasilyeva, N. V. Cherdyntseva, P. A. Gervas, V. A. Belyavskaya, M. B. Freidin (Tomsk, Kol‘tsovo, Novosibirsk Region, Russian Federation). Polymorphisms associated with lung cancer are closely related to COPD. Eur Respir J 2007; 30: Suppl. 51, 901
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Changes in the pulmonary microbiome associated with lung cancer
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Source: Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017
Year: 2017
Factors associated with regional occurance of lung cancer
Source: Annual Congress 2010 - Epidemiology of lung cancer
Year: 2010
Airway gene expression as a link between COPD and lung cancer
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009
Lung cancer and associated diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
Polymorphisms in telomere maintenance genes and risk of lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
Polymorphisms in the interleukin-10 gene promoter are associated with susceptibility to non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005
COPD susceptibility gene on chromosome 4q31 is also associated with lung cancer
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Telomere length, COPD and emphysema as risk factors for lung cancer
Source: Eur Respir J 2017; 49(1): 1601521; DOI: 10.1183/13993003.01521-2016
Year: 2017
Polymorphisms in cancer-related pathway genes and lung cancer
Source: Eur Respir J 2016; 48: 1184-1191
Year: 2016
Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002
Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019
Coexistence of COPD in lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
Risk factors for lung cancer in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Is
MIF -173G/C
polymorphism associated with in non-small cell lung cancer (NSCLC) susceptibility?
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept